Related Experiment Video
Updated: Aug 6, 2026
13:34
Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium
Published on: July 8, 2015
Synthesis, encapsulation, and cytotoxic effects of new Schiff-base copper complexes
Lucas M Bosquetti1, Vitória S Sousa1, Kaio S Gomes1
1Metal Biochemistry and Oxidative Stress Laboratory, Center for Natural Sciences and Humanities, Federal University of ABC - UFABC, Avenida dos Estados, 5001, 09210-580 Santo André, SP, Brazil.
Journal of Inorganic Biochemistry
|July 25, 2026
Summary
Novel copper(II) Schiff-base complexes show promise for treating glioblastoma. Liposomal encapsulation of a specific complex, OVDPCu, significantly enhanced its potency and selectivity against cancer cells.
Area of Science:
- Medicinal Chemistry
- Nanotechnology
- Oncology
Background:
- Gliomas are aggressive brain tumors with limited treatment options.
- Copper-based metallodrugs offer a novel therapeutic strategy but face challenges in stability and tumor targeting.
- Developing targeted drug delivery systems is crucial for improving cancer therapy efficacy.
Purpose of the Study:
- To synthesize and characterize novel copper(II) Schiff-base complexes for glioblastoma treatment.
- To investigate the structure-activity relationships of these complexes, focusing on coordination geometry.
- To evaluate the efficacy of liposomal encapsulation in enhancing the anti-cancer activity and tumor selectivity of a lead copper complex.
Main Methods:
- Synthesis and characterization of eight copper(II) Schiff-base complexes using various spectroscopic techniques (IR, UV-Vis, EPR) and elemental analysis.
- Liposomal encapsulation of complexes via solvent nanoprecipitation to form nanocarriers.
- In vitro cytotoxicity assessment using MTT assays against glioblastoma (LN-18) and non-tumorigenic (mHippoE-2) cell lines.
Main Results:
- Distinct coordination geometries were observed, with a square-planar N₂O₂ geometry in OVDPCu showing enhanced DNA-targeting potential.
- Liposomal encapsulation yielded monodisperse vesicles with 20-60% incorporation efficiency.
- OVDPCu demonstrated significant cytotoxicity against LN-18 cells, and its liposomal form showed a 3.8-fold increase in potency with a selectivity index of 5.1.
Conclusions:
- A clear structure-geometry-activity relationship was established for copper(II) Schiff-base complexes.
- Liposomal encapsulation of OVDPCu improves its therapeutic profile for glioblastoma by enhancing potency and selectivity.
- Encapsulated OVDPCu is a promising candidate for further preclinical development in glioblastoma treatment.
Related Concept Videos
01:19Phase II Reactions: Miscellaneous Conjugation Reactions
Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
00:56Extraction: Advanced Methods
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is formed in...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...